HomeCSBR • NASDAQ
Champions Oncology Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | 17.04M | 41.77% |
Operating expense | 5.92M | -12.21% |
Net income | 4.50M | 277.67% |
Net profit margin | 26.38 | 225.32% |
Earnings per share | 0.33 | 306.25% |
EBITDA | 4.90M | 333.64% |
Effective tax rate | 0.51% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.20M | -28.33% |
Total assets | 30.63M | 14.34% |
Total liabilities | 25.16M | -12.78% |
Total equity | 5.47M | — |
Shares outstanding | 13.71M | — |
Price to book | 21.53 | — |
Return on assets | 40.27% | — |
Return on capital | 116.18% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | 4.50M | 277.67% |
Cash from operations | 490.00K | 153.32% |
Cash from investing | -42.00K | 54.35% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 448.00K | 142.87% |
Free cash flow | -765.13K | -860.91% |
Previous close
$8.61
Year range
$3.60 - $11.99
Market cap
119.05M USD
Avg Volume
42.49K
P/E ratio
19.12
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1985
Headquarters
Website
Employees
210
